
TRex Bio, Inc.
Biological Products, (No Diagnostic Substances)
Company Overview
A concise company profile alongside the latest public filing activity.
TRex Bio is a clinical-stage biotechnology company developing medicines that modulate tissue-resident immune cells to treat autoimmune and inflammatory diseases. It is based in South San Francisco, California.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| SVLSF VI, LLC10% Owner | Buy | $1.26M | 89,783at $14.00 | Oct 8, 2026 |
| SVLSF VI, LLC10% Owner | Buy | $43K | 3,074at $14.00 | Oct 8, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable TRXB activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.